Characterizing the Mutational Landscape of Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Mexican Patients
International Journal of Molecular Sciences · 28.08.2024 · 25 (17) · 9328
DOI: 10.3390/ijms25179328 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.08.2024. Verfasst von Myrna Candelaria und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research, The National Cancer Institute, Ciudad de Mexico 14080, Mexico. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Mutation, Enhancer of Zeste Homolog 2 Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diffuse large B-cell lymphoma (DLBCL) is the most common B-cell malignancy worldwide. Molecular classifications have tried to improve cure rates. We prospectively examined and correlated the mutational landscape with the clinical features and outcomes of 185 Mexican patients (median age 59.3 years, 50% women) with newly diagnosed DLBCL. A customized panel of 79 genes was designed, based on previous international series. Most patients had ECOG performance status (PS) < 2 (69.2%), advanced-stage disease (72.4%), germinal-center phenotype (68.1%), and double-hit lymphomas (14.1%). One hundred and ten (59.5%) patients had at least one gene with driver mutations. The most common mutated genes were as follows: TP53, EZH2, CREBBP, NOTCH1, and KMT2D. The median follow-up was 42 months, and the 5-year relapse-free survival (RFS) and overall survival (OS) rates were 70% and 72%, respectively. In the multivariate analysis, both age > 50 years and ECOG PS > 2 were significantly associated with a worse OS. Our investigation did not reveal any discernible correlation between the presence of a specific mutation and survival. In conclusion, using a customized panel, we characterized the mutational landscape of a large cohort of Mexican DLBCL patients. These results need to be confirmed in further studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research, The National Cancer Institute, Ciudad de Mexico 14080, Mexico.
- Basic Research Division, Instituto Nacional de Cancerología, Ciudad de Mexico 14080, Mexico.
- Pathology Department, Instituto Nacional de Cancerología, Ciudad de Mexico 14080, Mexico.
- Unidad de Investigación Biomédica en Cancer, Instituto Nacional de Cancerología, Ciudad de Mexico 14080, Mexico.
- Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
ORCID-Profile: Myrna Candelaria, Dennis Cerrato-Izaguirre, Jose Diaz-Chavez, Alejandro Aviles
Zitieren
APA
Candelaria, M., Cerrato-Izaguirre, D., Gutierrez, O., Diaz-Chavez, J., Aviles, A., Dueñas-Gonzalez, A., & Malpica, L. (2024). Characterizing the Mutational Landscape of Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Mexican Patients. International Journal of Molecular Sciences, 25(17), 9328. https://doi.org/10.3390/ijms25179328
Vancouver
Candelaria M, Cerrato-Izaguirre D, Gutierrez O, Diaz-Chavez J, Aviles A, Dueñas-Gonzalez A, et al. Characterizing the Mutational Landscape of Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Mexican Patients. International Journal of Molecular Sciences. 2024;25(17):9328. doi:10.3390/ijms25179328
BibTeX
@article{Candelaria2024,
author = {Candelaria, Myrna and Cerrato-Izaguirre, Dennis and Gutierrez, Olga and Diaz-Chavez, Jose and Aviles, Alejandro and Dueñas-Gonzalez, Alfonso and Malpica, Luis},
title = {Characterizing the Mutational Landscape of Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Mexican Patients},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {17},
pages = {9328},
doi = {10.3390/ijms25179328}
}
EUVIMED